Fibrinogen administration in prehospital trauma

Cover image - FCThis report considers if Fibrinogen Concentrate (FC) is a reasonable alternative to allogeneic products in the prehospital setting by examining the literature regarding patient mortality, intensive care unit (ICU) length of stay, safety, need for additional blood products, storage, administration and costs.

Key points from the report:

  1. Current published evidence is low quality
  2. Suggests FC in hospital setting is safe and effective
  3. Logistic advantages for FC with storage, preparation and more rapid administration


In the absence of allogenic products, FC could be considered as a reasonable prehospital alternative. This is best conducted under clinical trial conditions.


Fibrinogen administration in prehospital trauma


For more information please contact:

Jon Newman
Project Officer
NSW Institute of Trauma and Injury Management
+61 2 9464 4663

ITIM Guidelines


Contact us



View all ITIM tweets


Loading latest video...

See all videos